Explore UAB

Please note: 
The UAB MGL has lifted the moratorium on the RNA-based biopsy testing of neurofibroma tumor samples (test code: NF14N). Clinical samples for NF14N testing can now be accepted. 

For all cell culture-based testing of CAL spot biopsies (NF14C) or neurofibroma tumor tissue (NF14N), the biopsy sample(s) must be collected in our cell culture media to be viable for testing. Please reach out to our lab at least one week prior to a scheduled biopsy procedure to request the media kit to ensure sufficient time for the kit to arrive before the scheduled date.  To request the required culture media, please complete a kit request here.

Instructions for collecting and shipping CAL spot biopsy specimens can be found here.

Instructions for collecting and shipping neurofibroma tumor specimens can be found here.

Given the complexities of these testing approaches, please contact the MGL if you are considering this test or would like to discuss a specific case.

For more information regarding the Medical Genomics Laboratory holiday closures and sample receival availability, please see Holiday Closures


The Medical Genomics Laboratory (MGL) is a CAP-certified nonprofit clinical laboratory at the University of Alabama at Birmingham, offering comprehensive testing for common and rare genetic disorders.  The MGL specializes in testing for all forms of the neurofibromatoses including NF1, Legius syndrome (SPRED1 disorder), segmental NF, NF-Noonan, spinal NF, Watson syndrome, NF2, and schwannomatosis as well as the RASopathies, and tuberous sclerosis complex. 


UAB Medical Genomics Laboratory
720 20th St. S., Suite 330
Birmingham, AL 35294
Phone: 205.934.5562
Fax: 205.996.2929
E-mail: medgenomics@uabmc.edu 

Tell us how we are doing! Please complete our customer satisfaction survey and share your feedback! Please click here for survey